c-KIT signaling is significantly increased in postmortem brains of AD and PD patients, while a recent report showed a pathogenic role for c-KIT-expressing mast cells mediating inflammation and neuromuscular junction denervation in muscles from SOD1G93A ALS rats (Trias et al., 2018). This evidence concerns the gene KIT and Parkinson disease.